Amy Hont, M.D.

  • Assistant Professor of Pediatrics
    • Fellowship, Pediatric Hematology/Oncology, Children's National Hospital, Washington DC (2015-2018) 
    • Residency, Pediatrics, University of Arizona, Tuscon, AZ (2012-2015)
    • M.D., Medicine, Ross University School of Medicine, Porstmouth, Dominica (2008-2012) 
    • B.S., Chemical Biology, University of California, Berkeley, CA (2002-2006)
  • Amy Hont, M.D., is an attending physician in the Department of Hematology/Oncology and physician-scientist in the Center for Cancer and Immunology Research. Her research interest focuses on the use of targeted therapies, including immunotherapy, for patients with high-risk malignancies. In particular she investigates the optimization of adoptive cell therapy for patients with relapsed or refractory solid tumor, including modification of T cell products and the tumor microenvironment.